PMID- 32267835 OWN - NLM STAT- MEDLINE DCOM- 20200727 LR - 20210806 IS - 1545-7885 (Electronic) IS - 1544-9173 (Print) IS - 1544-9173 (Linking) VI - 18 IP - 4 DP - 2020 Apr TI - YTHDF2 promotes mitotic entry and is regulated by cell cycle mediators. PG - e3000664 LID - 10.1371/journal.pbio.3000664 [doi] LID - e3000664 AB - The N6-methyladenosine (m6A) modification regulates mRNA stability and translation. Here, we show that transcriptomic m6A modification can be dynamic and the m6A reader protein YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) promotes mRNA decay during cell cycle. Depletion of YTHDF2 in HeLa cells leads to the delay of mitotic entry due to overaccumulation of negative regulators of cell cycle such as Wee1-like protein kinase (WEE1). We demonstrate that WEE1 transcripts contain m6A modification, which promotes their decay through YTHDF2. Moreover, we found that YTHDF2 protein stability is dependent on cyclin-dependent kinase 1 (CDK1) activity. Thus, CDK1, YTHDF2, and WEE1 form a feedforward regulatory loop to promote mitotic entry. We further identified Cullin 1 (CUL1), Cullin 4A (CUL4A), damaged DNA-binding protein 1 (DDB1), and S-phase kinase-associated protein 2 (SKP2) as components of E3 ubiquitin ligase complexes that mediate YTHDF2 proteolysis. Our study provides insights into how cell cycle mediators modulate transcriptomic m6A modification, which in turn regulates the cell cycle. FAU - Fei, Qili AU - Fei Q AUID- ORCID: 0000-0002-0860-2175 AD - Department of Chemistry, The University of Chicago, Chicago, Illinois, United States of America. AD - Howard Hughes Medical Institute, The University of Chicago, Chicago, Illinois, United States of America. AD - Guangdong Laboratory for Lingnan Modern Agriculture, Genome Analysis Laboratory of the Ministry of Agriculture, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences, Shenzhen, Guangdong, China. FAU - Zou, Zhongyu AU - Zou Z AD - Department of Chemistry, The University of Chicago, Chicago, Illinois, United States of America. AD - Howard Hughes Medical Institute, The University of Chicago, Chicago, Illinois, United States of America. FAU - Roundtree, Ian A AU - Roundtree IA AD - Department of Chemistry, The University of Chicago, Chicago, Illinois, United States of America. AD - Howard Hughes Medical Institute, The University of Chicago, Chicago, Illinois, United States of America. AD - Medical Scientist Training Program, The University of Chicago, Chicago, Illinois, United States of America. AD - Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois, United States of America. AD - Institute for Biophysical Dynamics, The University of Chicago, Chicago, Illinois, United States of America. FAU - Sun, Hui-Lung AU - Sun HL AUID- ORCID: 0000-0003-2273-311X AD - Department of Chemistry, The University of Chicago, Chicago, Illinois, United States of America. AD - Howard Hughes Medical Institute, The University of Chicago, Chicago, Illinois, United States of America. FAU - He, Chuan AU - He C AD - Department of Chemistry, The University of Chicago, Chicago, Illinois, United States of America. AD - Howard Hughes Medical Institute, The University of Chicago, Chicago, Illinois, United States of America. AD - Department of Biochemistry and Molecular Biology, The University of Chicago, Chicago, Illinois, United States of America. AD - Institute for Biophysical Dynamics, The University of Chicago, Chicago, Illinois, United States of America. LA - eng PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20200408 PL - United States TA - PLoS Biol JT - PLoS biology JID - 101183755 RN - 0 (Cell Cycle Proteins) RN - 0 (Cullin 1) RN - 0 (Cullin Proteins) RN - 0 (DDB1 protein, human) RN - 0 (DNA-Binding Proteins) RN - 0 (RNA-Binding Proteins) RN - 0 (S-Phase Kinase-Associated Proteins) RN - 0 (SKP2 protein, human) RN - 0 (YTHDF2 protein, human) RN - CLE6G00625 (N-methyladenosine) RN - EC 2.7.10.1 (Protein-Tyrosine Kinases) RN - EC 2.7.10.2 (WEE1 protein, human) RN - EC 2.7.11.22 (CDC2 Protein Kinase) RN - EC 2.7.11.22 (CDK1 protein, human) RN - K72T3FS567 (Adenosine) SB - IM MH - Adenosine/*analogs & derivatives/genetics/metabolism MH - CDC2 Protein Kinase/metabolism MH - Cell Cycle/*physiology MH - Cell Cycle Proteins/genetics MH - Cullin Proteins/metabolism MH - DNA-Binding Proteins/metabolism MH - HeLa Cells MH - Humans MH - Mitosis/*physiology MH - Protein Stability MH - Protein-Tyrosine Kinases/genetics MH - RNA Stability MH - RNA-Binding Proteins/genetics/*metabolism MH - S-Phase Kinase-Associated Proteins/metabolism PMC - PMC7170294 COIS- I have read the journal's policy and the authors of this manuscript have the following competing interests: C.H. is a scientific founder of Accent Therapeutics, Inc. and a member of its scientific advisory board. EDAT- 2020/04/09 06:00 MHDA- 2020/07/28 06:00 PMCR- 2020/04/08 CRDT- 2020/04/09 06:00 PHST- 2019/09/30 00:00 [received] PHST- 2020/03/20 00:00 [accepted] PHST- 2020/04/20 00:00 [revised] PHST- 2020/04/09 06:00 [pubmed] PHST- 2020/07/28 06:00 [medline] PHST- 2020/04/09 06:00 [entrez] PHST- 2020/04/08 00:00 [pmc-release] AID - PBIOLOGY-D-19-02876 [pii] AID - 10.1371/journal.pbio.3000664 [doi] PST - epublish SO - PLoS Biol. 2020 Apr 8;18(4):e3000664. doi: 10.1371/journal.pbio.3000664. eCollection 2020 Apr.